Ogorek Anthony Joseph Edwards Lifesciences Corp Transaction History

Ogorek Anthony Joseph

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$81.41 - $94.33 $25,562 - $29,619	-314 Reduced 65.55%	165 $15,000
Q1 2023 May 03, 2023	SELL	$74.26 - $84.51 $96,909 - $110,285	-1,305 Reduced 73.15%	479 $39,000
Q3 2021 Oct 27, 2021	BUY	$102.91 - $122.75 $32,313 - $38,543	314 Added 21.36%	1,784 $201,000
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $51,210 - $68,485	890 Added 153.45%	1,470 $102,000
Q1 2020 Apr 10, 2020	BUY	$52.41 - $81.0 $17,295 - $26,730	330 Added 132.0%	580 $109,000
Q2 2019 Jul 15, 2019	BUY	$55.74 - $64.41 $8,918 - $10,305	160 Added 177.78%	250 $46,000
Q3 2018 Oct 17, 2018	BUY	$45.7 - $58.03 $4,113 - $5,222	90 New	90 $15,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Ogorek Anthony Joseph , based on Form 13F filings with the SEC.

Stay updated on Ogorek Anthony Joseph with notifications on news.